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ApoptosisStroke most commonly results from occlusion of a major artery in the brain and typically leads to the death
of all cells within the affected tissue. Mitochondria are centrally involved in the development of this tissue
injury due to modiﬁcations of their major role in supplying ATP and to changes in their properties that can
contribute to the development of apoptotic and necrotic cell death. In animal models of stroke, the limited
availability of glucose and oxygen directly impairs oxidative metabolism in severely ischemic regions of the
affected tissue and leads to rapid changes in ATP and other energy-related metabolites. In the less-severely
ischemic “penumbral” tissue, more moderate alterations develop in these metabolites, associated with near
normal glucose use but impaired oxidative metabolism. This tissue remains potentially salvageable for at
least the ﬁrst few hours following stroke onset. Early restoration of blood ﬂow can result in substantial
recovery of energy-related metabolites throughout the affected tissue. However, glucose oxidation is
markedly decreased due both to lower energy requirements in the post-ischemic tissue and limitations on
the mitochondrial oxidation of pyruvate. A secondary deterioration of mitochondrial function subsequently
develops that may contribute to progression to cell loss. Mitochondrial release of multiple apoptogenic
proteins has been identiﬁed in ischemic and post-ischemic brain, mostly in neurons. Pharmacological
interventions and genetic modiﬁcations in rodent models strongly implicate caspase-dependent and
caspase-independent apoptosis and the mitochondrial permeability transition as important contributors to
tissue damage, particularly when induced by short periods of temporary focal ischemia.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Stroke is the primary cause of adult disability in developed coun-
tries and ranks only behind cancer and cardiac disease as a cause of
death [1,2]. Focal ischemia that results from occlusion of an artery in
the brain (ischemic stroke) accounts for more than 80% of all strokes
[1]. Unless rapidly reversed, the occlusion of a major artery usually
produces tissue infarction, inwhich affected parts of the brain exhibit a
non-selective loss of all cells including neurons, astrocytes, oligoden-
drocytes, microglia and endothelial cells. The size and location of these
infarcts are important determinants of the long-term functional
deﬁcits resulting from ischemic stroke. Mitochondria have been im-
plicated as central players in the development of ischemic cell death
both through impairment of their normal role in generating much of
the ATP for neural cell function and as key mediators in cell death121, A-kinase anchor protein
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ll rights reserved.pathways. This article reviews the current understanding of the
mitochondrial responses to focal cerebral ischemia and the contribu-
tions of these organelles to tissue damage. Additional aspects of this
topic and further discussion of some of the earlier studies can be found
in previous reviews [3–6].
2. Tissue damage in response to ischemic stroke
Occlusion of a major artery within the brain produces complex
cellular changes that depend in part on the severity of the ischemia that
is generated and whether the occlusion is temporary or permanent.
Because of the limited overlap in the perfusion territories of cerebral
arteries, severe ischemia develops in the tissue immediately surround-
ing the occluded vessel. Blood ﬂow usually falls to less than 20% of
normal in this “core” or “focal” tissue [7–9]. The resultant disruption to
delivery of glucose and oxygen leads to a greatly reduced ATP
generation (see section 4.1.1). Ionic gradients across the plasma
membrane quickly dissipate resulting in marked losses of intracellular
potassium and large shifts of calcium into cells [2,10,11]. Because of
contributions to perfusion from adjacent vessels, a lesser ischemia
develops in tissue surrounding the core. This “penumbral” or “perifocal”
tissue typically exhibits reductions to approximately 20–40% of normal
ﬂow [8,9,12]. Neurons in the penumbra are electrically silent for long
periods, a response associated with hyperpolarization of the plasma
membrane [8,12]. (Note: For simplicity, the term penumbra has been
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moderate ischemia, even though criteria other than direct measure-
ment of blood ﬂow or plasma membrane potential have commonly
been used.)
Following permanent arterial occlusion, infarcts initially develop
in the core tissue but progress to encompass both core and penumbral
regions [13,14]. The differences in the severity of the ischemia in the
core and penumbramean that differentmechanisms contribute to cell
death. Much of our understanding of the cellular changes induced by
focal ischemia comes from animal models of stroke and from the
effects of pharmacological treatments or genetic modiﬁcations on the
damage that develops. Permanent or temporary occlusion of the
middle cerebral artery (MCA) in rats or mice has commonly been used
for these investigations. The present review focuses primarily on
insights derived from such animal models into changes in energy
metabolism andmitochondrial properties within the ﬁrst few hours of
stroke and their involvement in cell death.
Many interventions during the initial few hours following the
onset of stroke in these models can reduce infarct volume, parti-
cularly in the penumbra [2,15]. Thus, irreversible damage develops
relatively slowly in this region. Consistent with this conclusion, early
restoration of blood ﬂow can reduce the tissue damage and
functional deﬁcits in animal models of stroke [16,17] and following
a stroke in humans [13,18]. Indeed, treatment with a thrombolytic
agent to reverse arterial occlusion within the ﬁrst 3 h following
stroke onset provides the only approach in routine clinical use for
limiting the acute effects of this disorder in humans [13,18].
Unfortunately, because of the narrow therapeutic window, only a
small proportion of those affected by stroke are currently treated
with thrombolysis. Spontaneous reversal of arterial occlusion occurs
within the ﬁrst 6 h in approximately 17% of ischemic stroke patients
and in approximately 40–50% by 4 days [19]. Reperfusion beginning
later than 6 h probably has limited effects on the tissue damage that
develops. Thus, animal models involving permanent arterial occlu-
sion, although less commonly investigated than temporary occlusion,
are likely to be more relevant to the majority of ischemic stroke cases
in humans.
Treatments targeting a diverse range of cellular properties have
been found to ameliorate tissue damage and improve functional
deﬁcits in animal models of stroke [2,15]. This suggests that the
mechanisms for cell loss involve interactions between multiple de-
leterious processes such that initial changes in one of these processes
leads to more severe alterations in others. Interruption of one of these
initial responses is apparently able to disrupt, or in some instances
greatly delay, the spiral of increasingly abnormal changes that
culminate in cell death. Intriguingly, treatments that reduce damage,
including those targeting properties of speciﬁc cell populations,
preserve essentially all cells in the tissue that is salvaged. A smaller
but still well-demarcated infarct results. Such a uniform demise of
different cell populations is not seen with many other insults and
suggests a close interdependence of the different cell populations in
their responses to ischemia.
Early studies demonstrated that pharmacological blockade of
ionotropic glutamate receptors markedly reduced ischemic damage
[2,15,20]. This effect is commonly ascribed to the involvement of an
excitotoxic process in which increases in glutamate release from
neurons and astrocytes induced by the ischemia cause an excessive
calcium entry via these receptors and triggers other intracellular
changes leading to cell death. However, alternative mechanisms have
also been suggested to explain the protection by glutamate receptor
antagonists, including interference with the propagation of poten-
tially harmful spreading depression-like depolarizations that develop
in the penumbral tissue during arterial occlusion [15,21]. Abnormal
intracellular calcium accumulations arising from calcium entry via ion
channels or transporters in addition to the ionotropic glutamate
receptors have also been implicated in triggering cell death [20].Other changes identiﬁed as important in ischemia-induced cell
loss include oxidative stress, particularly involving nitric oxide and
peroxynitrite, and abnormal activation of enzymes such as poly-ADP
ribose polymerase (PARP) and the calpains [2,15]. Early reperfusion
can limit the effects of some of these changes but also adds to the
complexity of the cellular responses that develop. Oxidative stress is
promoted under these conditions and inﬂammatory responses, ari-
sing both from resident microglia and astrocytes as well as blood-
derived cells, also become important [2,15].
3. The nature of cell death in focal ischemia
Cell death resulting from cerebral ischemia was originally
considered to be almost exclusively due to the process of necrosis in
which catastrophic events initiated by ischemia led to cellular changes
culminating in organelle swelling, disruption of the plasmamembrane
and release of intracellular contents. These features of cell death are
usually seen in the vast majority of cells throughout the developing
infarct [22]. Nonetheless, a more complex picture began to emerge in
the mid-1990's with the identiﬁcation of cells that exhibited features
of apoptosis, including DNA fragmentation and the production of
membrane enclosed apoptotic bodies [23,24]. Such changes are
common features of cell death mediated by the activation of caspases
either via the “intrinsic pathway” or the “extrinsic pathway” [3,25,26].
Mitochondrial changes resulting in the release of proteins are central
to the intrinsic pathway (Fig. 1). These proteins lead to the activation
of caspases, particularly caspase-3 in brain, which in turn induces
cellular changes including internucleosomal chromatin condensation
and DNA fragmentation [3,25–27]. The role of the intrinsic pathway in
focal ischemia is discussed in section 5.2. The extrinsic pathway is
triggered by the binding of speciﬁc ligands to plasma membrane cell
death receptors. This leads to intracellular activation of caspase-8 and
then of executioner caspases involved in cell death. In the extrinsic
pathway, the executioner caspase activation can occur without
involvement of mitochondria [3,26]. However, caspase-8 activation
can also cleave Bid to produce truncatedBid (t-Bid),which initiates the
release of apoptogenic proteins from mitochondria under some
conditions. Caspase-independent forms of apoptosis (Fig. 1), which
result from mitochondrial release of apoptosis inducing factor (AIF)
and perhaps other proteins [3,25,26], have also been implicated in
focal ischemic damage (see section 5.3).
Cells exhibiting features of apoptosis typically peak in number at
24 h or longer after stroke onset [23,24,28]. They are found scattered
throughout the infarct following temporary or permanent occlusion
but are more prominent in tissue subject to less severe ischemia
within the penumbra and are more numerous in brains subjected to
temporary ischemia lasting up to 2 h [23,24,28–30]. This form of cell
loss shows a closer association with tissue that is potentially sal-
vageable and has attracted particular attention as a target for neuro-
protective therapies.
Attempts to characterize the mechanisms underlying ischemic cell
loss have been further complicated with the recognition that necrosis
also often involves speciﬁc patterns of cellular change that can develop
overmanyhours. Furthermore, these responses can behighly regulated,
or even programmed, and are potentially modiﬁable [26,31,32].
Alterations contributing to cerebral ischemic damage, including
increased intracellular calcium and oxidative stress, have been
identiﬁed as potential players in necrotic-like programmed cell death.
However, the extent to which such a programmed form of necrosis
might contribute to focal ischemic damage is not currently known.
4. Mitochondrial function and ATP generation during cerebral
ischemia and reperfusion
Mitochondrial function in focal ischemia is altered as a direct
consequence of the impaired delivery of glucose and oxygen to the
Fig. 1. Proteins released from the intermembrane space that can contribute to the development of apoptosis. The release of cytochrome c is a key step in the intrinsic pathway of
apoptosis. This forms a complex known as an apoptosome with the proteins APAF-1 and procaspase-9 and with dATP. Apoptosome formation leads to activation of executioner
caspases, particularly caspase-3, that results in internucleosomal protein degradation and other cellular changes. This process can be promoted by the release of Smac/DIABLO and
Omi/HtrA2 that act to block IAPs, a family of proteins that are endogenous inhibitors of caspase-3 and other caspases. The release of AIF leads to a caspase-independent form of
apoptosis. AIF interacts with other proteins to also produce DNA degradation, generating larger fragments of DNA than the caspase-dependent pathway. An interaction of AIF with
cyclophilin A is essential for the development of this process, at least under some conditions. Endonuclease G, another protein released from the mitochondria, might also be
involved in this process.
Table 1
The effects of focal ischemia for up to 2 h and of subsequent reperfusion for 1 h on the
content of energy-related metabolites and pathways of energy metabolism.
Focal ischemia Reperfusion
Core Penumbra Core Penumbra
Metabolites
ATP ↓↓↓ ↓↓ ↓↓ ↓
Adenylate energy charge ↓↓ ↓ ↓/N.C. N.C.
Total adenine nucleotides ↓↓ ↓↓ ↓↓ ↓
Phosphocreatine ↓↓↓ ↓ ↓ N.C.
Lactate ↑↑ ↑↑ ↑↑ ↑/N.C.
Glucose ↓↓↓ N.C. N.C. N.C.
Metabolic activity
Glucose use ↓↓↓⁎ N.C. ↓↓ ↓↓
Oxidative metabolism ↓↓↓⁎ ↓↓↓ ↓↓ ↓↓
Differences are shown compared to non-ischemic tissue. ↓: decreased to N65%; ↓↓:
decreased to between 35% and 65% ; ↓↓↓: decreased to less than 35%; ↑: increased less
than four-fold; ↑↑: increased greater than four-fold; N.C.: no signiﬁcant change. Two
symbols indicate ﬁndings that differ between published reports. ⁎, direct evaluation of
these properties in severely ischemic tissue may not give reliable information. The
magnitude of these reductions is assumed from the large decrease in substrate delivery
and large changes in ATP and phosphocreatine content.
Information adapted from results presented in [9,13,33–36,39–41,45,46].
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that develop during ischemia or following reperfusion. Limitations in
the ability of cells to generate ATP can exacerbate the cellular res-
ponse to other insults and can greatly inﬂuence the cell death path-
ways that develop. Thus, an understanding of the pattern of changes
in cellular energy metabolism is essential to fully elucidate the
mechanisms leading to tissue damage in ischemia. Furthermore,
because the generation of ATP requires the integration of complex
metabolic processes, the characterization of energy-related metabo-
lites and of the pathways involved in their production provides a
useful indicator of both the extent of preservation of essential cellular
functions and the extent of cell damage or cell death in the tissue.
4.1. Energy metabolism during ischemia
Table 1 summarizes alterations in the content of energy-related
metabolites and in the contributing metabolic pathways in brain
tissue during ischemia and following reperfusion. An overview of the
relevant metabolic processes is provided in Fig. 2, which further
highlights the changes that develop in penumbral tissue during the
initial 2–3 h of focal ischemia.
4.1.1. Core tissue
Within the severely ischemic core, the large reductions in blood
ﬂow lead to impaired delivery of oxygen and glucose and a mismatch
between ATP use and production. Glucose and ATP content falls
markedly during the ﬁrst 5 min or so of arterial occlusion [33]. ATP
stabilizes at values approximately 15–30% of those in non-ischemic
tissue for at least the ﬁrst 2 h of focal ischemia [33–36]. The initial
rapid decrease in ATP content is associated with the major
redistribution of ions across the plasma membrane of cells [10,11]
and probably triggers this response [37]. The adenylate energy charge
([ATP]+0.5 [ADP]/[ATP]+[ADP]+[AMP]) which measures the
intracellular balance between ATP, ADP and AMP is also rapidly
decreased and is maintained at values of approximately 0.4–0.5
during the initial hours of focal ischemia, much lower than values in
normal brain (of approximately 0.93) [33–35].Phosphocreatine in brain tissue provides a short-term energy
reserve, allowing ATP to be regenerated from ADP in a near-
equilibrium reaction catalysed by creatine kinase. Phosphocreatine
shows a similar pattern of change to ATP, rapidly falling to values less
than 30% of normal [33–36]. Limitations in the availability of oxygen
ensure that some of the glucose that does reach core tissue is
metabolised via glycolysis to lactate with an associated decrease in
pH. Lactate accumulates to values more than 10-fold that of non-
ischemic tissue [34,36]. Reduced removal of the lactate because of the
limited blood ﬂow probably also contributes to this increase.
4.1.2. Penumbral tissue
A pattern of changes in energy metabolites similar to that in the
ischemic core develops in the penumbral tissue but the alterations are
Fig. 2. Overview of the pathways of energy metabolism in cells in the brain, highlighting the major changes seen in these metabolic pathways and energy-related tissue metabolites
in the penumbra within the ﬁrst 2 h of stroke onset. In animal models of stroke, most cells in the penumbra remain viable during this initial period of focal ischemia and can survive if
there is early restoration of blood ﬂow or treatments that block other cellular changes critical for cell death. A single arrow indicates a moderate change and a double arrow a large
change. N.C., no signiﬁcant change from control values; ANT, adenine nucleotide translocase; ETC, electron transport chain; PC, pyruvate carrier. Information on metabolic status
adapted from results presented in [9,13,33–36,39–41].
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reduced to approximately 70% of non-ischemic values and the ade-
nylate energy charge remains above 0.8 [34]. Larger decreases are
seen in ATP, with values approaching 50% of non-ischemic tissue at
2 h of ischemia [34]. Under ischemic conditions, some of the ADP
generated from ATP hydrolysis is further metabolised to AMP and ATP
[38]. This reaction, catalysed by adenylate kinase, normally helps to
maintain ATP and meet short-term energy demands in the brain. In
ischemic tissue, the AMP is further converted to inosine and
hypoxanthine resulting in overall depletion of the adenine nucleotide
pool [38]. The greater severity of the ATP loss compared with changes
in other energy-related metabolites is to a large extent explained by
this decrease in the total adenine nucleotide pool.
Surprisingly, glucose utilization in penumbral tissue as assessed
from metabolism of deoxyglucose is unchanged or even increased
during the ﬁrst 2 h of ischemia [9,13]. An increase in glucose extraction
from the blood helps to largely preserve the tissue glucose content
[33,39] contributing to the maintenance of glycolytic activity. There is
an increase in lactate within the penumbra to valuesmany times higher
than in normal brain but less than in the core regions [34,36]. The
accumulation of lactate suggests that oxygen delivery is more severely
restricted than that of glucose, resulting in impaired oxidative
metabolism of pyruvate by the mitochondria. Magnetic resonance
spectroscopic analysis of the products of isotopically labelled glucose
provides support for this conclusion [40,41]. In particular, these studies
show reductions of more than 50% in the generation of isotopically
labelled glutamate from glucose. The total glutamate content in the
tissue is unchanged at this time. The incorporation of label from glucose
into glutamate, which occurs predominantly in neurons [41–43],
requires generation of pyruvate via glycolysis, metabolism of pyruvate
to α-ketoglutarate via the tricarboxylic acid cycle and subsequent
conversion to glutamate (Fig. 2). Some caution is needed in interpretingthese ﬁndings because of the possible confounding effects of ischemia-
induced changes in the size of intermediate metabolite pools as well as
any moderate changes that may exist in delivery of the labelled
precursors. Nonetheless, the results strongly suggest markedly reduced
oxidative metabolism of glucose in the penumbral tissue in contrast to
the preservation of glycolysis.
The reduced oxidativemetabolism in penumbral tissuemeans that
there is unlikely to be reserve capacity to deal with increases in energy
requirements. This conclusion is supported by comparisons of the
metabolic response to spreading depression-like depolarizations that
develop in the penumbra compared with KCl-induced spreading
depression in normal brain [44]. Similar proportional decreases in ATP
and phosphocreatine are induced by the advancing depolarization of
the tissue in both situations. However, the penumbral tissue shows
much larger increases in lactate and a greatly reduced ability to
restore the ATP and phosphocreatine content. These changes limit the
capacity of the tissue to reverse changes initiated by the redistribution
of ions during the spreading depression, increasing the likelihood of
deleterious consequences.
4.2. Energy metabolism following reperfusion
4.2.1. Core tissue
The greatly impaired production of ATP, the major redistribution
of ions and derangement of othermetabolic properties in the ischemic
core are incompatible with cell survival if they are not rapidly
reversed. However, the initial development of these changes within
core tissue during the ﬁrst 5 min or so of arterial occlusion does not
immediately produce irreversible cellular deterioration. Restoration
of blood ﬂow during the ﬁrst 30 to 60 min in rats and mice greatly
limits the size of the infarcts that subsequently develop [16,17] and
can completely block cell loss, indicating that the development of
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delayed. Even with ischemic periods up to 3 h, which will ultimately
lead to infarction, there is often near-complete recovery of phospho-
creatine (to more than 90% of pre-ischemic values) and of the
adenylate energy charge (or other measures of adenine nucleotide
balance) during the ﬁrst 2 h following reperfusion [34,36,39,45,46].
The recovery of these metabolic parameters requires the presence of
intact and functional cells that at least partially regain the complex
metabolic activities and control processes required to meet energy
demands. The concentration of ATP in core tissue recovers more
slowly than phosphocreatine or the adenylate energy charge fol-
lowing restoration of blood ﬂow, reaching 50–70% of control values
within the ﬁrst hours. This ongoing decrease in ATP is mostly due to
the slow resynthesis of the adenine nucleotide pool that was depleted
during ischemia, with lesser contributions from an imbalance bet-
ween ATP use and production.
With further perfusion following longer ischemic periods that are
sufﬁcient to initiate infarct formation, the core tissue typically exhibits
a secondary decline in energy-related metabolites that is most likely
associated with ﬁnal progression to the death of many cells [34,39].
Such cell loss in the core tissue is generally an inevitable consequence
of ischemic periods lasting more than an hour but might not be
irreversibly determined in all parts of this tissue at the onset of
reperfusion. Large reductions in infarct size (exceeding 50%) have
been achieved with some treatments initiated early after reperfusion
following ischemic periods of at least 2 h (e.g., [47–50]). Although the
penumbra is the predominant site of this protection, the magnitude of
the effects suggests that parts of the core tissue are also salvaged. The
initial near-complete restoration of energymetabolites on reperfusion
is consistent with the possibility that cells in parts of the core can still
be rescued. When temporary arterial occlusion exceeds 3 h, reperfu-
sion results in less complete restoration of energy metabolites and a
more rapid onset of secondary deterioration in the core regions,
indicating that many cells are much more severely compromised at
the time of reperfusion [39].
The substantial restoration of the content of energy-related
metabolites is not an indication of comparable recovery of the activity
of energy-generating metabolism. At 1 h of reperfusion following 2 h of
ischemia in rats, glucose utilization, as assessed from deoxyglucose
incorporation, is reduced to approximately 50% of normal values in
tissue regions that formed the ischemic core [9]. Furthermore, the
lactate content remains many times higher than in normal tissue sug-
gesting ongoing restrictions on the oxidative metabolism of pyruvate
[34,36,39,45,46]. Consistent with these results, the generation of
isotopically labelled glutamate from glucose is also markedly decreased
[41,46] indicating greatly reduced neuronal energy metabolism.
4.2.2. Penumbral tissue
Reperfusion in the penumbral tissue leads to complete or near-
complete recovery of phosphocreatine and the adenine nucleotide
balancewithin the ﬁrst hour of reperfusion following ischemic periods
lasting up to 3 h or even longer [34,39,45,46]. The restoration of ATP
content is less complete, again because of slow regeneration of the
depleted adenine nucleotide pool. A secondary disruption of energy
metabolites associated with gross disruption of cellular function
typically occurs at 6 or more hours after the initiation of reﬂow [39].
The timing of these changes is broadly consistent with the ﬁnding in
human stroke that damage can be reduced and function improved if
ﬂow is restored within 3 h and perhaps after longer periods [8,18].
As in the core tissue, the onset of reperfusion leads to reductions
(by approximately 40%) in glucose use (assessed using deoxyglucose)
in the penumbra within the ﬁrst hour, a ﬁnding which contrasts with
the preservation of this activity during ischemia [9]. Even larger
reductions in the oxidative metabolism of glucose develop in this
tissue within the ﬁrst hour of reperfusion, as determined from the
incorporation of isotopic label from glucose into glutamate [41,46].Lactate is substantially decreased compared with the large accumula-
tions during ischemia. However, it usually remains signiﬁcantly ele-
vated following ischemic insults of sufﬁcient duration to generate
infarcts encompassing the former penumbral tissue [34,46] (but see
also [36,41]), consistent with ongoing restrictions in pyruvate
oxidation. Despite the size of the reductions in oxidative glucose
metabolism, this change is not inevitably associated with the deve-
lopment of infarcts. Similar metabolic decreases are also seen with
shorter ischemic periods that generally do not result in infarcts within
the reperfused penumbral tissue [46].
As indicated previously, the isotopic labelling of glutamate from
glucose primarily (but not exclusively) reﬂects neuronal metabolism
and provides one of only a fewmeasures available to evaluate aspects of
metabolism selectively in this cell population [41–43]. A selective
measure of the oxidative metabolism of astrocytes in the brain can also
be obtained based on the incorporation of isotopic label from acetate to
glutamine [41–43]. The selectivity results from the ability of glia but not
neurons to take up acetate and convert it to acetyl CoA [51] and from the
almost exclusive localization of the enzyme catalysing glutamine
production (glutamine synthetase) in astrocytes [52]. The production
of isotopically labelled glutamine from acetate is unchanged or even
increased in the penumbra comparedwithnormal tissueduring theﬁrst
hour following reperfusion [41,53]. This measure of metabolic activity
continues to be nearly fully preserved for at least 4 h in reperfused
penumbral tissue that is destined to become infarcted [53]. These results
indicate that the majority of astrocytes remain viable in this tissue and
preserve important features of oxidative metabolism for extended
periods following temporary ischemia.
The ﬁnding of greatly reduced glucose conversion to glutamate but
well-preserved astrocytic acetate metabolism could possibly indicate
large differences in the functional preservation of astrocytes com-
pared with neurons during early reperfusion of penumbral tissue.
Alternatively, the limitations on glucose metabolism might be similar
in the two cell populations but the decrease in glucose metabolism
results from the effects of cellular controls or other changes de-
creasing activity at steps prior to acetyl CoA. If so, these restrictions on
metabolismwould be by-passed by the use of acetate as themetabolic
precursor. The latter explanation is supported by analyses using
magnetic resonance spectroscopy of the labelling patterns of
individual carbons in glutamate and glutamine following injection
of 13C-glucose [41]. This approach allows a comparison of carbons
entering the tricarboxylic acid cycle via the anaplerotic reaction
catalysed by pyruvate carboxylase, which is speciﬁc to astrocytes, and
those entering via pyruvate dehydrogenase, which occurs in neurons
and astrocytes. The proportional contribution of these two pathways
is similar in reperfused penumbral tissue and in normal tissue [41].
Thus, glucose metabolism is apparently similarly affected in both cell
types following reperfusion of the penumbral tissue.
The near-complete restoration of phosphocreatine and the
adenylate energy charge following reperfusion in the penumbra
despite marked decreases in activity of the relevant ATP-generating
metabolic pathways from glucose implies that energy-requiring
functions are greatly reduced in the post-ischemic brain. This could
arise partly from decreases in neuronal activity that are induced
during ischemia and persist for long periods in post-ischemic brain
[54,55]. A further likely major contributor to reductions in energy use
in post-ischemic brain is the enzyme, AMP-activated protein kinase.
This kinase is activated by many stimuli including ATP depletion and
other changes produced by cerebral ischemia [56]. It induces multiple
cellular alterations that reduce anabolic reactions and help to restore
energy balance. The activity of AMP-activated protein kinase is
increased by phosphorylation. Long-lasting increases in phosphory-
lated AMP-activated protein kinase are seen following reperfusion
throughout the brain, including tissue from the ischemic penumbra,
non-ischemic tissue and, to a lesser extent, core tissue [56,57]. Inte-
restingly, inhibition of AMP-activated kinase initiated at the time of
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an activator of this enzyme causes increased damage [57,58].
Protection is also seen in genetically modiﬁed mice that do not
express the α2 isoform of AMP-activated protein kinase [58]. Thus,
changes leading to activation of this enzyme are deleterious in post-
ischemic brain even though they can be protective following a more
mild insult.
4.3. Other mitochondrial changes during ischemia and reperfusion
The capacity of mitochondria for respiratory activity has been
evaluated based on oxygen utilization in preparations from brain
tissue removed during focal ischemia and following reperfusion. For
samples obtained during ischemia, there is a progressive deterioration
of the ability of the mitochondria to increase activity of the electron
transport chain in response to decreases in the proton gradient across
the inner mitochondrial membrane induced by the addition of ADP or
an uncoupling agent [16,59,60]. Basal respiration is largely preserved.
By 2 h of MCA occlusion in rats, the ADP-stimulated or uncoupled
respiration decreases by 45–60% in samples from core tissue.
Reductions of 15–40% are seen in the penumbra. This reduced
respiratory capacity in the penumbral mitochondria could exacerbate
the effects of lower oxygen delivery and contribute to the decreases in
oxidative metabolism in this region.
As is the case for energy metabolites, mitochondrial respiratory
function is generally completely or near-completely restored in
samples prepared from core and penumbral tissue within the ﬁrst
hour following reperfusion [16,59,60] but then declines at later times
[59,60]. Interestingly, this secondary deterioration in mitochondrial
respiration apparently develops earlier than the changes in energy-
related metabolites when assessed in the same ischemic model
[34,59], suggesting that the delayed alterations in mitochondrial
function are an early step in the development of irreversible cell
dysfunction and possibly a contributor to this process. As seenwith the
energy-related metabolites, there is less restoration of mitochondrial
function in core tissue evaluated during early reperfusion following
longer periods of ischemia [16]. Mitochondria isolated from this core
tissue also exhibit a lowermembrane potential when incubated under
basal or ADP-stimulated conditions, providing further evidence of a
decreased capacity for ATP generation in these organelles [61].
Electronmicrographs of brain tissue at 2 h after reversal of a 3 h period
of focal ischemia have revealed marked structural abnormalities of
mitochondria in neurons [62], consistent with the functional deteri-
oration seen under similar conditions in other studies. Interestingly,
the structural alterations following reperfusion resembled those
generated by much longer periods of permanent ischemia.
Although there are many potential mechanisms for disease-
induced impairments of respiratory function andmembrane potential
in brain mitochondria [6], the molecular processes underlying the
changes induced by ischemia and reperfusion are not known.
Alterations in respiratory function are not explained by decreased
activity of individual components of the electron transport chain as
these are essentially fully preserved during ischemia and reperfusion
[63]. Some subtle alterations in activities of these respiratory chain
complexes in localised parts of the core tissue have been detected by
immunohistochemical techniques [64]. These are most obvious at 4 h
following reperfusion andmay be associated with the development of
early pockets of secondary deterioration in mitochondrial function.
Ischemia-induced changes in A-kinase anchor protein 121
(AKAP121) is a possible contributor to the altered mitochondrial
properties. This protein was recently found to be degraded in neurons
during focal cerebral ischemia [65], albeit in samples obtained at 24 h
of permanent ischemia when interpretation is complicated by the
advanced state of tissue damage. AKAP121 forms a complex on the
outermitochondrialmembrane that is involved in inducing changes in
mitochondrial functions in response to intracellular signalling path-ways. Of particular interest, degradation of AKAP121 results in im-
paired oxidative metabolism and decreased membrane potential in
the mitochondria [65]. Further studies are needed to assess the effects
of shorter ischemic periods and of reperfusion on AKAP121 to evaluate
its possible role in altered mitochondrial respiration.
5. Mitochondria and cell death pathways
The major deﬁcits in mitochondrial ATP production in severely
ischemic core tissue create conditions that ensure the development of
necrotic death in all cells within a few hours of stroke onset. This
tissue provides no prospects for promoting cell survival unless there is
early reperfusion. The milder metabolic deﬁcits in the penumbra
allow longer survival of the cells and provide opportunities for
protective interventions. Nonetheless, in the absence of reperfusion or
other treatments, metabolic changes arising from the limited
availability of substrates for oxidative metabolism and probably also
from progressive deterioration of mitochondrial function again
contributes to the demise of cells in this region. Other mitochondrial
changes, including induction of the permeability transition and the
release of proteins that trigger apoptosis, have also been implicated in
tissue damage, particularly in the reperfused penumbra as discussed
in the following sections.
5.1. The mitochondrial permeability transition and ischemic cell death
The mitochondrial permeability transition results from opening of
a pore in the inner mitochondrial membrane that is non-selectively
permeable to solutes smaller than 1.5 kDa [66–68]. Transition pore
opening is usually induced by abnormal accumulations of calcium and
can be promoted by multiple factors including depletion of adenine
nucleotides and oxidative stress. Despite intensive research, the
composition of the permeability transition pore remains incompletely
understood. Three proteins have been strongly implicated: the
adenine nucleotide translocase in the inner mitochondrial membrane,
the voltage-dependent anion carrier in the outer membrane and
cyclophilin D, a matrix protein with peptidyl-prolyl cis-trans isome-
rase activity [66–68]. Studies in mice that do not express cyclophilin D
have conﬁrmed a key role for this protein in development of the
transition pore, although this componentmay be unnecessary for pore
opening at very high calcium concentrations [69–71]. However, some
doubts have been raised about the role of the adenine nucleotide
translocase becausemitochondria frommice lacking expression of the
major isoforms of this protein can still develop a permeability
transition [67,72].
Involvement of the permeability transition in ischemic cell death
was initially suggested by the ability of cyclosporin A to produce
dramatic reductions in tissue infarction (by 65–90%) when given
immediately following reperfusion [49,73,74]. Cyclosporin A inhibits
transition pore opening by binding to cyclophilin D. Interpretation of
this result is not straightforward because cyclosporin A also has other
effects that might have contributed to the observed protection
including inhibition of the protein phosphatase, calcineurin. FK506, a
compound that inhibits calcineurin but does not block the permeabi-
lity transition, can also decrease infarct volume [49,75]. Nonetheless,
impressive protection has been demonstrated when derivatives of
cyclosporin A that do not inhibit calcineurin have been administered at
the time of reperfusion [73,76]. In one of these studies, the inhibitor
also decreased cytochrome c release to the cytosol but did not alter the
respiratory function of mitochondria isolated from affected tissue
early in the post-ischemic period [76].
The strongest evidence for a role for the mitochondrial permeabil-
ity transition in ischemic damage is provided by the much smaller
infarcts that develop in mice lacking the protein cyclophilin D [71]. As
expected, knockout of cyclophilin D interferes with the development
of the permeability transition in mitochondria. Intriguingly, cells from
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exposure to hydrogen peroxide and a calcium ionophore but not to
commonly used inducers of apoptosis such as staurosporine [69–71].
This ﬁnding is consistent with the permeability transition (or at least
forms of the permeability transition involving cyclophilin D) being
primarily involved in necrotic cell death. Thus, the improved outcome
with inhibitors acting via cyclophilin D and in the cyclophilin D−/−
mice probably involves disruption to necrosis in the affected tissue.
The effects of deletion of cyclophilin D and of inhibitors of the
permeability transition indicate a major role for this process in
promoting cell death following temporary ischemia. However, the
nature of this role is not yet fully understood. Halestrap [66] and Leung
and Halestrap [67] have proposed a mechanism for permeability
transition involvement in necrotic cell death in temporary ischemia of
the heart or brain. They suggest that calcium accumulation during the
ischemic period establishes conditions for pore opening but that
induction is initially blocked by the lowered pH associatedwith lactate
production. Changes initiated on reperfusion including a burst of free
radical production result in opening of the pore. The inability of
mitochondria to then generate ATP and the depletion of cytosolic ATP
due to reversal of the ATP synthase lead to major metabolic
derangements and ultimately activation of degradative enzymes
leading to necrosis. At least for focal ischemia in brain, thismechanism
is difﬁcult to reconcile with the extent of recovery of energy-related
metabolites during early reperfusion in core and penumbral tissue
destined to become part of the infarct [34,39,45,46]. The near normal
respiratory properties of mitochondria assessed in preparations from
tissue early after reperfusion [16,59,60] are also at variance with
induction of the permeability transition unless this was reversed
during sample processing. Alternative mechanisms may be involved
including a slower onset of the permeability transition that contributes
to the secondary decline in energy metabolism or a possible transient
induction of the permeability transition during early reperfusion that
initiates changes leading to a more slowly developing programmed
form of necrosis.
The evidence that the permeability transition is involved in
necrosis suggests that this change might also contribute to cell loss
in the penumbra in permanent ischemia but this possibility has
received little attention. Protection has been achieved using cyclos-
porin A treatment in permanent ischemia [77,78]. However, similar
protection was also provided by FK506 suggesting that induction of
the permeability transition was not involved. Further investigations
are needed.
5.2. Caspase-dependent apoptosis
The intrinsic pathway of apoptosis requires the release to the
cytosol of speciﬁc proteins that normally reside in the intermembrane
space of mitochondria [3,25–27] (Fig. 1). The best characterized of
these apoptogenic mitochondrial proteins is the electron transport
chain component, cytochrome c. Within the cytosol, cytochrome c
forms a complex referred to as an apoptosome with procaspase-9,
apoptotic protease activating factor 1 (APAF-1) and dATP. The for-
mation of the apoptosome activates caspase-9 which then cleaves
other procaspases. The activation of caspase-3 by this process is
particularly important. Caspase-3 and other executioner caspases have
multiple effects including proteolysis of an inhibitor of the caspase-
activated DNase [3,25–27]. Degradation of the inhibitor results in
translocation of caspase-activated DNase to the nucleus where it
catalyses internucleosomal DNA degradation producing fragments
containing multiples of 180–200 base pairs.
A release of cytochrome c to the cytosol following temporary
ischemia has been widely observed either using immunohistochem-
istry on brain sections or Western blotting of tissue subfractions (see
for example [79–85]). This change is usually only detected in neurons.
Occasional cells exhibiting cytochrome c release are seen within theﬁrst hour following reperfusion. The number of affected cells typically
increases substantially over the next few hours and then remains
stable or increases further to 24 h. One study has reported changes
restricted to penumbral tissue at 4 h following onset of reperfusion
[81], but alterations more typically develop in some neurons within
tissue that formed part of both the core and penumbral regions during
arterial occlusion. In response to permanent ischemia, cytochrome c
release also develops within a few hours in neurons spread
throughout the ischemic tissue [30,86–88]. The active cleaved form
of caspase-9 has also been detected in neurons and appears with a
similar time course to that for the release of cytochrome c following
temporary focal ischemia [79,83,87], further suggesting the develop-
ment of the intrinsic pathway of apoptosis in these cells.
At least two other proteins released from the intermembrane
space also promote caspase-dependent apoptosis but less directly
than cytochrome c [3,25,26]. Both second mitochondria-derived
activator of caspase/direct IAP-binding protein of low pI (Smac/
DIABLO) and Omi stress-regulated endoprotease/high temperature
requirement protein A2 (Omi/HtrA2) bind to and block the action of
members of the family of inhibitor-of-apoptosis proteins (IAPs). IAPs
inhibit caspase-3, caspase-7 and caspase-9. By blocking this effect,
Smac/DIABLO and Omi/HtrA2 increase the consequences of caspase
activation and promote cell death. Omi/HtrA2 but not Smac/DIABLO
has a proteolytic activity that contributes to the inhibitory effects on
IAPs [3,25]. Smac/DIABLO and Omi/HtrA2 increase in the cytosol of
neurons following temporary focal ischemia with a time course that is
similar to that of cytochrome c [79,80,83,89]. Interactions between
Omi/HtrA2 and XIAP, the most potent member of the IAP family, have
been detected by co-immunoprecipitation [89]. A delayed increase in
cleaved XIAP was also seen in one study [80]. Treatment of rats with
an inhibitor of Omi/HtrA2 activity shortly before induction of tem-
porary ischemia was found to moderately reduce DNA damage in the
post-ischemic tissue [80].
Taken together, these ﬁndings indicate that the intrinsic pathway
of apoptosis is activated in some neurons affected by focal ischemia.
The initial study describing cytochrome c release in focal ischemia [82]
identiﬁed cells exhibiting this change that also showed features of
apoptotic cell death, as indicated by positive TUNEL staining and the
presence of apoptotic bodies. However, there was not a close rela-
tionship between cytosolic cytochrome c and this apoptotic morpho-
logy. The patterns of release of cytochrome c and other proteins in
subsequent studies also do not suggest a close correlation with the
distribution of cells exhibiting morphological features of apoptosis in
the affected cells. A likely explanation for this limited correlation is
that the internal pathway of apoptosis is induced in the mitochondria
of the neurons showing cytoplasmic accumulation of mitochondrial
proteins but that the further development of caspase-dependent
apoptosis is overwhelmed by other molecular changes that result in
alternative forms of cell death, at least in some of these cells. It is also
likely that some of the cytochrome c release results from a disruption
to mitochondrial structure that is unrelated to induction of caspase-
dependent apoptosis.
Increases in the active cleaved form of caspase-3 are also seen
following temporary ischemia with a time course and distribution
similar to that for the release of proteins from the mitochondrial
intermembrane space [80,81,83,90,91]. Expression is again almost
exclusively detected in neurons. Mice lacking expression of caspase-3
usually die during development. However, a strain that survives to
maturity develops markedly smaller infarcts than wild-type mice
following 2 h of MCA occlusion [92]. The interpretation of this ﬁnding
is complicated because the mice exhibit changes in brain structure,
including an increased density of neurons in the cortex, arising from
the lack of caspase-3 during development. Nonetheless, the results
point to an important contribution of caspase-mediated cell death to
ischemic damage following temporary focal ischemia. Further support
for this conclusion is provided by substantial decreases in infarct
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ischemia with a pan-caspase inhibitor as well as an inhibitor that is
relatively selective for caspase-3 [93,94]. A similar protection has also
been produced by an inhibitor with selectivity for caspase-9 [95],
consistent with a role for cytochrome c release in the development of
damage.
These ﬁndings strongly suggest the activation of caspase-dependent
apoptosis following temporary focal ischemia, at least in part via the
intrinsic pathway. However, the relative contribution of the extrinsic
and intrinsic apoptotic pathways to the caspase activation is not
known. A signiﬁcant role for the extrinsic pathway in inducing caspase
activation is suggested by the identiﬁcation of changes in upstream
signalling proteins in post-ischemic brain and the development of
much smaller infarcts following temporary ischemia in mice lacking
components of this pathway [96,97].
Activation of caspase-3 has been less studied in permanent focal
ischemia. Direct evaluation of brain tissue for caspase-3 activation
during a focal ischemic insult that was restricted to the cortex identi-
ﬁed changes only in someof the neurons in one cortical layer, although
more widespread activation was seen in microglia [98]. Furthermore,
treatment of rats with a caspase inhibitor prior to induction of
permanent ischemia did not signiﬁcantly improve infarction [99]
suggesting that this form of cell death may be of little importance
unless there is reperfusion.
5.3. Caspase-independent apoptosis
Mitochondrial membrane permeabilization can also lead to the
release of proteins that trigger apoptosis by caspase-independent
pathways [3,25,26]. The best studiedmediator of this formof cell death
is AIF. AIF under normal conditions is a transmembrane protein of
approximately 62 kDa that resides in the inner mitochondrial mem-
brane. Following outer membrane permeabilization, the portion of AIF
(approximately 57 kDa) in the intermembrane space is released by
proteolysis, via actions of calcium-activated calpains and calcium-
independent cathepsins [25,26]. The AIF translocates to the nucleus
where it triggers the degradation of DNA into fragments that are larger
than those produced following caspase-3 activation. AIF does not have
intrinsic nuclease activity. Thus, the DNA degradation requires
activation of one or more other proteins. Interactions of AIF with the
protein, cyclophin A in the cytosol and co-translocation of the two
proteins lead to DNA degradation [3,25,26,100]. These interactions are
essential for AIF-mediated apoptosis, at least under some conditions.
In focal ischemia, nuclear translocation of AIF is seen in some
neurons within the ﬁrst 2 h following short periods of focal ischemia
(of less than 1 h) in mice and then increases greatly over the next 24 h
[90,101–103]. Such changes are usually present in tissue from the core
and penumbral regions [101] (but see [81]) and again are essentially
restricted to neurons. By 24 h after an ischemic period of 45 min,
nuclear translocation of AIF was seen in many neurons and correlated
closely with overall neuronal loss [101]. Following longer periods of
temporary ischemia and in permanent ischemia, nuclear translocation
is apparently not initiated for several hours but again increases at later
times [84,102].
The most direct evidence that AIF contributes to ischemic damage
is provided by large reductions in infarct size seen following 45min of
MCA occlusion in Harlequin mice. Expression of AIF in these mice is
reduced to approximately 20% [101]. Brain development in Harlequin
mice is apparently normal although the decrease in AIF also alters
antioxidant defences, which could potentially inﬂuence the tissue
damage that develops [26]. Further support for the importance of AIF
in cell death is provided by the large protective effects resulting from
knockout of the PARP gene or inhibition of PARP in ischemic and post-
ischemic brain. The activation of this enzyme by ischemia is believed
to lead to cell death that at least in part involves AIF release and
nuclear translocation (as discussed further in section 5.4.3).Endonuclease G, another protein released from mitochondria, can
interact with AIF under some conditions and can directly cause
caspase-independent apoptosis [3,25,26]. In temporary or permanent
ischemia, endonuclease G translocation to the nucleus follows a similar
time course to AIF and is seen in neurons throughout the perfusion
territory of the occluded artery [103,104]. Co-immunoprecipitation
studies suggest that endonuclease G interactswith AIF in the nucleus at
24 h following temporary focal ischemia [102].
5.4. Inducers and modulators of mitochondrial involvement in cell death
5.4.1. Promoters of outer membrane permeabilization
The mechanisms for release of apoptogenic proteins from the
intermembrane space to the cytosol during development of apoptosis
has been intensively studied over the last decade but remains
incompletely understood [3,25]. Under normal conditions, the
presence of the voltage-dependent anion carrier in the outer
mitochondrial membrane allows compounds with molecular weights
below 1.5 kDa to readily move between the cytosol and intermem-
brane space. However, the release from the intermembrane space of
larger molecules, including cytochrome c and other proteins, requires
a substantial increase in permeability of the outer mitochondrial
membrane. Under some conditions, this can result from formation of
the mitochondrial transition pore which leads to permeabilization of
the inner membrane. Subsequent swelling of the mitochondria due to
water entry into the matrix following pore opening results in
disruption of the outer membrane and the release of proteins from
the intermembrane space [3,25]. As discussed further in section 4.1.,
there is considerable evidence for induction of the mitochondrial
permeability transition by focal ischemia and a prominent role for this
change in cell death under some conditions. However, the studies of
cells from mice lacking cyclophilin D expression [69–71] suggest that
this is more likely to result in necrosis than apoptosis.
An alternative process is now thought to be more commonly
involved in the permeabilization of the outer mitochondrial mem-
brane and release of apoptogenic proteins. This involves pore
formation by pro-apoptotic members of the Bcl-2 family of proteins
in the outer membrane [3,25]. The full details of this process are not
yet elucidated but translocation of the proteins, Bim and Bax, from the
cytosol to the mitochondrial membrane is commonly involved.
Translocation of both proteins develops in the initial 4 h following 1
h of ischemia in rats and mice [83]. The expression of these proteins is
also increased at these times [81,83]. Translocation of Bax and Bim to
themitochondria following ischemia apparently involves activation of
c-Jun N-terminal kinase (JNK). Pretreatment of mice with a JNK
inhibitor immediately prior to 1 h of ischemia in mice decreases
movement of these proteins to the mitochondria and decreases the
number of cells exhibiting features of apoptosis, predominantly in
penumbral regions [83,105]. Movement of the Bcl-2 family protein,
Bad, from the cytosol to the mitochondria can also contribute to
mitochondrial membrane permeabilization under some circum-
stances. Translocation of this protein has also been detected following
temporary ischemia [106] (but see also [83]).
Activation of caspase-8 by cell death receptors involved in the
extrinsic apoptotic pathway can result in cleavage of another Bcl-2
family protein, Bid, and translocation of the t-Bid to the mitochondria
where it promotes release of apoptogenic proteins. Cleavage of Bid
develops following temporary ischemia, consistent with stimulation
of this arm of the extrinsic pathway [85,107]. Furthermore, infarct
volumes were found to be 67% smaller in Bid−/− mice compared to
wild-type mice exposed to brief (30 min) focal ischemia [107] and
approximately 30% smaller following more prolonged (90 min)
ischemia [85]. The Bid−/−mice also exhibited markedly diminished
and delayed cytochrome c release [85,107], less caspase-3 activation
as well as decreases in apoptotic neurons in tissue from the penumbra
[85]. Bid has also been implicated in promoting release of AIF in
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[101,108] and may therefore also contribute to caspase-independent
apoptosis in ischemia.
Other members of the Bcl-2 family are anti-apoptotic either by
binding pro-apoptotic Bcl-2 family proteins or via direct interactions
with the mitochondria [3,25]. These proteins can provide protection
against apoptotic and necrotic forms of cell death. The effects of over-
expression of two of these proteins, Bcl-2 and Bcl-xL, have been
investigated in permanent ischemia in mice and found to moderately
reduce infarcts in some studies but not others [109–111]. Local
increases in Bcl-2 expression achieved using viral vectors impeded
release of cytochrome c and the translocation of AIF to the nucleus in
neurons in the rim of infarcts produced by permanent ischemia in rats
and increased the survival of these neurons [112].
5.4.2. Oxidative stress
Oxidative stress has been strongly implicated as an important
factor in the development of both necrosis and apoptosis in focal
ischemia, particularly when there is reperfusion [2,15]. Peroxynitrite
generated from the reaction of nitric oxide and superoxide plays a
prominent role. Mitochondria are a major site of production of super-
oxide in normal cells and probably contribute to increased oxidative
stress in ischemic and post-ischemic brain. Consistent with this
possibility, over-expression of Mn2+-superoxide dismutase, the mito-
chondrial isoform of the enzyme that converts superoxide to
hydrogen peroxide, results in moderate reductions in infarction in
temporary ischemia [113]. Furthermore, much larger infarcts are seen
in mice heterozygous for deletion of this enzyme compared with
wild-type mice following both permanent and temporary ischemia
[29,114].
A decrease in mitochondrial generation of free radicals has been
proposed as the basis for reductions in tissue infarction in rats treated
systemically with a mild dose of the mitochondrial uncoupling agent,
dinitrophenol, following temporary ischemia [115]. Mitochondria
isolated from the penumbra but not the core of control rats during
early recirculation showedmoderate increases in calcium content and
an increase in production of free radicals when incubated in vitro.
These changes were both substantially reduced in mitochondria from
rats treated with dinitrophenol, consistent with a mitochondrial
contribution to the protection [115].
The major water-soluble antioxidant, glutathione, is localized in
both the cytosol and the mitochondria of cells. A selective loss of theFig. 3. Summary of major changes in mitochondrial properties that are induced by perman
conditions.mitochondrial pool develops during ischemic periods that are sufﬁcient
to induce infarct formation and persists during reperfusion [116]. In
astrocytes in culture, losses of mitochondrial glutathione increase sus-
ceptibility to oxidative and nitrative stress but not to inducers of
apoptosis [117,118]. Interestingly, the increased vulnerability in these
cells apparently involves induction of the permeability transition and
resembles the effects on cell viability produced by knockout of cyclo-
philin D [118]. The decrease in mitochondrial glutathione also seems
likely to promote necrosis in ischemic and post-ischemic brain but
deﬁnitive evidence is lacking.
The involvement of superoxide in the development of ischemic
injury has beenmost extensively characterized through investigations
of mice overexpressing the cytosolic enzyme, Cu2+ Zn2+-superoxide
dismutase. These animals develop smaller infarcts than wild-type
mice following temporary ischemia but, interestingly, not permanent
ischemia [119,120]. Following reperfusion, this enzyme leads to
decreases in multiple events associated with mitochondrially medi-
ated apoptosis including the release of cytochrome c, Smac/DIABLO
and Omi/HtrA2 and translocation of Bad to the mitochondria
[89,106,121,122].
5.4.3. PARP activation
PARP is an enzyme that is activated by DNA damage and generates
poly-ADP ribose to promote repair [123]. A role for PARP activation in
ischemic cell death is demonstrated by the development of much
smaller infarct volumes (typically reduced by more than 50%) in
response to temporary ischemia in PARP−/− mice [124–126] or in
rats and mice treated with PARP inhibitors [47,48,125]. Decreases of
infarct formation can be achieved with treatments several hours after
recirculation in temporary ischemia. Markedly reduced damage is also
achieved by PARP inhibition initiatedwithin the ﬁrst 2 h of permanent
ischemia [48]. The effects of PARP are explained, at least partially, by
the ability of poly-ADP ribose to trigger release of AIF [127]. PARP
inhibition decreases AIF translocation in response to focal ischemia
[101]. Furthermore, both poly-ADP ribose formation and AIF translo-
cation induced by focal ischemia are attenuated by inhibitors of nitric
oxide synthase and are also decreased in mice in which the gene for
neuronal nitric oxide synthase is deleted [84]. Thus, PARP activation
and subsequent AIF translocation are apparently consequences of
initial induction of oxidative damage to DNA induced by peroxynitrite.
PARP activation can also initiate necrosis under some conditions
[31]. Excessive activity of PARP depletes cellular NAD+, the substrateent or temporary focal cerebral ischemia and can contribute to cell death under some
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in an attempt to regenerate the NAD+ [6,31]. The decrease in these
key intermediates of energy generation can initiate cellular changes
that result in necrotic forms of cell death. The effectiveness of PARP
inhibition in limiting damage induced by both temporary and
permanent ischemia could reﬂect the involvement of this enzyme in
the development of more than one form of cell death in the ischemic
and post-ischemic brain.
6. Conclusions
Cell death in stroke develops on a background of complex meta-
bolic changes that depend on the severity and duration of the focal
ischemic insult. Fig. 3 summarizes key alterations identiﬁed in mito-
chondrial properties that can contribute to cell death under some
conditions in ischemic or post-ischemic brain. In severely ischemic
core tissue, oxidative glucose metabolism is rapidly impaired by
decreases in oxygen and glucose availability. These changes are not
compatible with long-term cell survival. Necrosis in this tissue is a
major contributor to infarct development in permanent ischemia. Of
greater interest, energy metabolism in the penumbra is more
moderately affected, almost certainly contributing to the ability of
this tissue to be rescued by some pharmacological interventions (in
animal models but not yet in humans) or by restitution of blood ﬂow
(in both animal models and humans) within the ﬁrst few hours of
stroke onset. In untreated permanent ischemia or with longer-term
ischemia with reperfusion, impairment of mitochondrial oxidative
metabolism and losses of glutathione from these organelles are likely
promoters of the cell death in the penumbra that results in expansion
of the infarct.
The development of the mitochondrial permeability transition and
the release of mitochondrial proteins leading to caspase-dependent
and caspase-independent apoptosis have all been shown to be
involved in ischemic damage in animal models of stroke. A role for
each of these processes in cell death, andparticularly neuronal death, is
best established in models of temporary ischemia, often of short
duration. Thus, these responses may well contribute to the damage
that develops following early restorationof bloodﬂow inhuman stroke
treatedwith thrombolysis or in the small proportion of caseswith early
spontaneous reperfusion. There has been much less investigation of
whether these processes might also contribute signiﬁcantly to the loss
of the potentially salvageable cells in the penumbra under conditions
of permanent or long-duration ischemia that are probably more
relevant to the majority of stroke in humans. The limited evidence
available suggests that neither caspase-dependent cell death nor the
permeability transition is likely to have amajor role. A possible broader
involvement of AIF translocation is suggested by the substantial effects
of inhibition of PARP in temporary and permanent ischemia, which are
mediated at least in part by nuclear translocation of AIF. Further
evaluation of the contribution of AIF is needed. Regardless of the
ischemic conditions, there is little evidence implicating any of these
three processes in the death of non-neuronal cells. The effects of
ischemia on the mitochondrial properties of these non-neuronal cells
and the interactions between these cells and neurons undergoing
necrosis or apoptosis are currently poorly understood and also need
further investigation.
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